EssilorLuxottica (ESLOY) Projected to Post Earnings on Tuesday

EssilorLuxottica (OTCMKTS:ESLOY) is expected to announce its resultson Tuesday, July 28th. Analysts expect EssilorLuxottica to announce earnings of $2.22 per share and revenue of $17.0774 billion for the quarter.

EssilorLuxottica Stock Up 0.2%

Shares of ESLOY stock opened at $95.23 on Tuesday. The business’s fifty day moving average is $99.50 and its 200 day moving average is $120.96. The company has a quick ratio of 0.70, a current ratio of 0.99 and a debt-to-equity ratio of 0.17. EssilorLuxottica has a twelve month low of $91.57 and a twelve month high of $186.81.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on ESLOY. Deutsche Bank Aktiengesellschaft started coverage on shares of EssilorLuxottica in a research report on Tuesday, May 12th. They issued a “hold” rating on the stock. The Goldman Sachs Group cut shares of EssilorLuxottica from a “buy” rating to a “hold” rating in a research report on Tuesday, July 14th. Finally, Zacks Research lowered shares of EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research note on Tuesday, June 23rd. Two analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, EssilorLuxottica has an average rating of “Moderate Buy”.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.